01st week of 2018 patent applcation highlights part 8 |
Patent application number | Title | Published |
20180000703 | METHOD AND KIT FOR PROCESSING HAIR | 2018-01-04 |
20180000704 | USES OF CO-CRYSTALS | 2018-01-04 |
20180000705 | Shampoo Compositions Comprising a Chelant | 2018-01-04 |
20180000706 | Conditioner Composition Comprising a Chelant | 2018-01-04 |
20180000707 | SUNSCREEN/INSECT REPELLANT COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | 2018-01-04 |
20180000708 | ANTIPERSPIRANTS HAVING INCREASED EFFECTIVENESS | 2018-01-04 |
20180000709 | CLEANSING COMPOSITION | 2018-01-04 |
20180000710 | ORAL COMPOSITION FOR TOOTH WHITENING PRODUCT, AND KIT COMPRISING SAME | 2018-01-04 |
20180000711 | POTASSIUM-CONTAINING AMPHOACETATE AND BETAINE SURFACTANTS | 2018-01-04 |
20180000712 | PARTICULAR PYRIDINEDICARBOXYLIC ACID DERIVATIVE/ANTIOXIDANT COMBINATION | 2018-01-04 |
20180000713 | Shampoo Compositions Comprising a Chelant | 2018-01-04 |
20180000714 | Conditioner Composition Comprising a Chelant | 2018-01-04 |
20180000715 | Hair Care Compositions For Calcium Chelation | 2018-01-04 |
20180000716 | MOISTURIZING BASE MATERIAL CONTAINING LIPID PEPTIDE COMPOUND | 2018-01-04 |
20180000717 | PEPTIDIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES OF SAID COMPOUNDS, IN PARTICULAR COSMETIC USES | 2018-01-04 |
20180000718 | HAIR CLEANSING CONDITIONER | 2018-01-04 |
20180000719 | A SKIN LIGHTENING COMPOSITION COMPRISING NIACINAMIDE AND ILOMASTAT | 2018-01-04 |
20180000720 | CROSSLINKABLE COATING COMPOSITIONS FORMULATED WITH DORMANT CARBAMATE INITIATOR | 2018-01-04 |
20180000721 | HYDROPHOBIC TOPICAL COMPOSITIONS AND METHODS FOR PRODUCING SAME | 2018-01-04 |
20180000722 | PREPARATION FOR PROTECTING AGAINST EXTRINSIC AND INTRINSIC SKIN AGING | 2018-01-04 |
20180000723 | COMPOSITIONS INCLUDING BAUHINIA, METHODS OF MAKING AND USING THE SAME IN SKIN ANTI-AGING AND OTHER SKIN APPLICATIONS | 2018-01-04 |
20180000724 | METHODS FOR INDUCING AN IMMUNE RESPONSE VIA BUCCAL AND/OR SUBLINGUAL ADMINISTRATION OF A VACCINE | 2018-01-04 |
20180000725 | ORALLY-DISSOLVING FILMS FOR DRUG DELIVERY THROUGH THE ORAL CAVITY | 2018-01-04 |
20180000726 | SUBLINGUAL AND BUCCAL FILM COMPOSITIONS | 2018-01-04 |
20180000727 | COMPOSITION AND METHODS TO IMPROVE STABILITY, DOSING, PHARMACODYNAMICS AND PRODUCT SHELF LIFE OF ENDOCANNABINOIDS, PHYTOCANNABINOIDS AND SYNTHETIC CANNABINOIDS DELIVERED BY NASAL INHAER | 2018-01-04 |
20180000728 | PHARMACEUTICAL FORMULATIONS OF TROPOMYOSIN RELATED KINASE (TRK) INHIBITORS | 2018-01-04 |
20180000729 | DEPOT FORMULATIONS | 2018-01-04 |
20180000730 | ORAL DISINTEGRATING TABLET | 2018-01-04 |
20180000731 | Low-Temperature Inhalation Administration of Cannabinoid Entities | 2018-01-04 |
20180000732 | EMULSIONS FOR PARENTERAL ADMINISTRATION | 2018-01-04 |
20180000733 | SAFE AND STABLE ANTISEPTIC SOLUTION COMPRISING CHLORHEXIDINE | 2018-01-04 |
20180000734 | Wax Foamable Vehicle and Pharmaceutical Compositions Thereof | 2018-01-04 |
20180000735 | METHODS AND DEVICES FOR PREPARATION OF LIPID NANOPARTICLES | 2018-01-04 |
20180000736 | METHODS FOR THE REGENERATION OF ARTICULAR CARTILAGE IN VIVO | 2018-01-04 |
20180000737 | INJECTABLE AGGREGATES FOR JOINT AND SOFT TISSUE DISTRESS | 2018-01-04 |
20180000738 | NOVEL SPRAY NOZZLE AND PROCESS FOR MAKING NANOPARTICLES | 2018-01-04 |
20180000739 | ACTIVE INGREDIENT CONTAINING STABILISED SOLID FORMS AND METHOD FOR THE PRODUCTION THEREOF | 2018-01-04 |
20180000740 | PHARMACEUTICAL COMPOSITIONS FOR COLON-SPECIFIC DELIVERY | 2018-01-04 |
20180000741 | NOVEL PHARMACEUTICAL COMPOSITION | 2018-01-04 |
20180000742 | Pharmaceutical Composition for Oral Insulin Administration Comprising a Tablet Core and a Polyvinyl Alcohol Coating | 2018-01-04 |
20180000743 | Modified Alginate Hydrogels for Therapeutic Agents, their Preparation and Methods Thereof | 2018-01-04 |
20180000744 | NANOENCAPSULATED COMPOSITIONS | 2018-01-04 |
20180000745 | CRUCIFERIN COATED NANOPARTICLES | 2018-01-04 |
20180000746 | TRANSDERMAL DELIVERY SYSTEM CONTAINING METHYLPHENIDATE OR ITS SALTS AND METHODS THEREOF | 2018-01-04 |
20180000747 | METHODS FOR IMMUNOMODULATION OF CANCER AND INFECTIOUS DISEASE THERAPY | 2018-01-04 |
20180000748 | Tincture For Infusing Flavonoids And Methods Of Use | 2018-01-04 |
20180000749 | POLYMORPHIC AND AMORPHOUS FORMS OF (R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIENYL)B- UTANAMIDE | 2018-01-04 |
20180000750 | ANTIPLATELET AGENT AND USES THEREOF | 2018-01-04 |
20180000751 | INTRAVENOUS ADMINISTRATION OF TRAMADOL | 2018-01-04 |
20180000752 | Pulsed Release Phenylephrine Dosage Forms | 2018-01-04 |
20180000753 | EUTECTIC SOLVENTS AND USES THEREOF | 2018-01-04 |
20180000754 | METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA) | 2018-01-04 |
20180000755 | AGENT FOR CONTROLLING CELLS CONSTITUTING CANCER MICROENVIRONMENT OR INFLAMMATORY MICROENVIRONMENT | 2018-01-04 |
20180000756 | COMPOSITIONS, METHODS AND DEVICES FOR FORMING IMPLANTS FROM INJECTED LIQUIDS | 2018-01-04 |
20180000757 | SOLID-FORMING LOCAL ANESTHETIC FORMULATIONS FOR PAIN CONTROL | 2018-01-04 |
20180000758 | COMPOSITIONS AND METHODS FOR TREATMENT OF LUNG DISORDERS CHARACTERIZED BY CHOLESTEROL DYSREGULATION | 2018-01-04 |
20180000759 | LYOPHILIZED MESNA COMPOSITIONS | 2018-01-04 |
20180000760 | SYSTEMS AND METHODS FOR TREATING VITILIGO | 2018-01-04 |
20180000761 | Methods for Making Catechin Derivatives | 2018-01-04 |
20180000762 | COMPOSITION AND METHOD FOR MUSCLE REPAIR AND REGENERATION | 2018-01-04 |
20180000763 | Compositions and Methods for Treating Cardiovascular Diseases | 2018-01-04 |
20180000764 | MIXTURE OF CARBOXYLIC ACIDS FOR TREATING PATIENTS WITH KIDNEY FAILURE | 2018-01-04 |
20180000765 | COMPOSITIONS FOR THE TREATMENT OF AUTODIGESTION | 2018-01-04 |
20180000766 | COMPOSITIONS COMPRISING MAGNOLIA, PHELLODENDRON, THEANINE AND/OR WHEY PROTEIN | 2018-01-04 |
20180000767 | THERAPEUTIC TARGET FOR THE TREATMENT OF CANCERS AND RELATED THERAPIES AND METHODS | 2018-01-04 |
20180000768 | INTESTINAL FXR AGONISM ENHANCES GLP-1 SIGNALING TO RESTORE PANCREATIC BETA CELL FUNCTIONS | 2018-01-04 |
20180000769 | COMPOSITIONS AND METHODS FOR STIMULATING VENTILATORY AND/OR RESPIRATORY DRIVE | 2018-01-04 |
20180000770 | Methods of Treating Multiple Sclerosis | 2018-01-04 |
20180000771 | AGENT FOR PREVENTING AND/OR TREATING AMYOTROPHIC LATERAL SCLEROSIS | 2018-01-04 |
20180000772 | ZINC COMPLEXES OF HYDRAZONES AND (THIO)SEMICARBAZONES AND THEIR USE FOR THE TREATMENT OF CANCER | 2018-01-04 |
20180000773 | SUSPENSION COMPOSITIONS OF PHYSIOLOGICALLY ACTIVE PHENOLIC COMPOUNDS & METHODS OF MAKING AND USING THE SAME | 2018-01-04 |
20180000774 | METHODS OF TREATING COGNITIVE AND BEHAVIORAL IMPAIRMENT IN DOWN SYNDROME AND ALZHEIMERS DISEASE PATIENTS | 2018-01-04 |
20180000775 | TREATMENT FOR NON-ALCOHOLIC FATTY LIVER DISEASES | 2018-01-04 |
20180000776 | FORMULATION FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS | 2018-01-04 |
20180000777 | Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders | 2018-01-04 |
20180000778 | SMALL MOLECULE ANTAGONISTS OF DUSP5 AND METHODS OF USE | 2018-01-04 |
20180000779 | COMBINATION DRUG | 2018-01-04 |
20180000780 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | 2018-01-04 |
20180000781 | Compositions for Preventing and Treating Pulmonary Injury due to Ionizing Radiation or Cytotoxic Drugs | 2018-01-04 |
20180000782 | THERAPEUTIC AGENT FOR KERATOCONJUNCTIVE DISORDERS | 2018-01-04 |
20180000783 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MYCOSIS | 2018-01-04 |
20180000784 | PAR4 INHIBITOR THERAPY FOR PATIENTS WITH PAR4 POLYMORPHISM | 2018-01-04 |
20180000785 | METHODS FOR TREATING DEGENERATIVE DISEASES/INJURIES | 2018-01-04 |
20180000786 | 1H-Pyrazolo[4,3-b]pyridines as PDE1 Inhibitors | 2018-01-04 |
20180000787 | ALKALOIDS FROM SPONGE, SCAFFOLDS FOR THE INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) | 2018-01-04 |
20180000788 | CYCLIC UREAS AS INHIBITORS OF ROCK | 2018-01-04 |
20180000789 | FORMULATIONS OF BENDAMUSTINE | 2018-01-04 |
20180000790 | [1,2,4]TRIAZOLO[1,5-a]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS | 2018-01-04 |
20180000791 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH ANGIOGENESIS USING A VASCULAR ADHESION PROTEIN-1 (VAP-1) INHIBITOR | 2018-01-04 |
20180000792 | MODIFIED RELEASE COMPOSITIONS OF EPALRESTAT OR A DERIVATIVE THEREOF AND METHODS FOR USING THE SAME | 2018-01-04 |
20180000793 | Inhibiting Germination of Clostridium Perfringens Spores to Reduce Necrotic Enteritis | 2018-01-04 |
20180000794 | COMPOSITION FOR PREVENTION OR TREATMENT OF BRONCHIAL ASTHMA COMPRISING PKR INHIBITOR AS ACTIVE INGREDIENT | 2018-01-04 |
20180000795 | FACTOR XIa INHIBITORS | 2018-01-04 |
20180000796 | TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING VALENTONIN AND USE THEREOF AS A MEDICAMENT | 2018-01-04 |
20180000797 | OCT3 ACTIVITY INHIBITOR CONTAINING IMIDAZOPYRIDINE DERIVATIVE AS ACTIVE COMPONENT, AND OCT3 DETECTION AGENT | 2018-01-04 |
20180000798 | USE OF ACLIDINIUM | 2018-01-04 |
20180000799 | 3-ALKYL PYRIDINIUM COMPOUND FROM RED SEA SPONGE WITH POTENT ANTIVIRAL ACTIVITY | 2018-01-04 |
20180000800 | COMBINATION THERAPY FOR TREATMENT OF RESISTANT BACTERIAL INFECTIONS | 2018-01-04 |
20180000801 | COMPOSITIONS OF FATOSTATIN BASED HETEROCYCLIC COMPOUNDS AND USES THEREOF | 2018-01-04 |
20180000802 | PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF MENTAL DISEASE WITH ENHANCED NMDAR FUNCTION | 2018-01-04 |